Skip to main content

Report: Security Lapses in Handling of Deadly Pathogens

A government report finds that laboratories in the U.S. that work with select agents such as Ebola and anthrax aren’t as secure as they should be.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

ISTOCK, JARUN011A year-long government investigation has found that the program responsible for overseeing the laboratories that handle some of the world’s deadliest pathogens is prone to safety lapses, raising concerns about effective oversight.

Research on select agents—hazardous pathogens and toxins including Ebola and smallpox viruses and the bacteria that cause anthrax and the plague—requires federal oversight and adherence to strict regulations. However, in a report released today (October 31), the Government Accountability Office (GAO) uncovered a number of flaws in biosafety measures taken by approved laboratories and a lack of independent oversight. Ultimately, the GAO came to the conclusion that the Federal Select Agent Program, which oversees 276 “high-containment” laboratories in the U.S. that undertake research on select agents, “does not meet our key elements of effective oversight.”

There have been several severe safety lapses in recent years. In 2014, for example, a scientist at the National Institute of Health discovered a number of decades-old vials of smallpox ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays